Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors

BACKGROUND: Clinical trials have reported the efficacy of tropomyosin receptor kinase (TRK) inhibitors against neurotrophic receptor tyrosine kinase (NTRK) fusion gene-positive advanced solid tumors. The accumulated evidence of tumor-agnostic agent has made since TRK inhibitors were approved and use...

Descripción completa

Detalles Bibliográficos
Autores principales: Naito, Yoichi, Mishima, Saori, Akagi, Kiwamu, Hayashi, Naomi, Hirasawa, Akira, Hishiki, Tomoro, Igarashi, Ataru, Ikeda, Masafumi, Kadowaki, Shigenori, Kajiyama, Hiroaki, Kato, Motohiro, Kenmotsu, Hirotsugu, Kodera, Yasuhiro, Komine, Keigo, Koyama, Takafumi, Maeda, Osamu, Miyachi, Mitsuru, Nishihara, Hiroshi, Nishiyama, Hiroyuki, Ohga, Shouichi, Okamoto, Wataru, Oki, Eiji, Ono, Shigeru, Sanada, Masashi, Sekine, Ikuo, Takano, Tadao, Tao, Kayoko, Terashima, Keita, Tsuchihara, Katsuya, Yatabe, Yasushi, Yoshino, Takayuki, Baba, Eishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310565/
https://www.ncbi.nlm.nih.gov/pubmed/37212982
http://dx.doi.org/10.1007/s10147-023-02345-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310565/
https://www.ncbi.nlm.nih.gov/pubmed/37212982
http://dx.doi.org/10.1007/s10147-023-02345-7

Ejemplares similares